Avaí Bio and Austrianova agree on insulin-producing cells for diabetes therapy

The announcement centers on a partnership with Austrianova to advance a cell-based diabetes treatment, with Avaí Bio also citing an internationally acclaimed partner.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.